FluoroPharma Medical, Inc. (FPMI) Supported by a Stellar Scientific Advisory Board
FluoroPharma Medical, developer of advanced medical diagnostic imaging products, with a current focus on imaging agents for breakthrough positron emission tomography (PET) applications, obtains critical advice and guidance from a scientific advisory board made up of top experts in the fields of medical imagery and cardiology. • Daniel Berman, MD, FACC, is Chief of Cardiac Imaging and Nuclear Cardiology at Cedars-Sinai Heart Center and Professor of Medicine at the David Geffen School of Medicine at the University of California, Los Angeles. A world-renowned expert in nuclear cardiology (the use of noninvasive nuclear imaging for the study of cardiovascular disease), he…